Disease: Post-transplant lymphoproliferative disease
- <em>Talaromyces marneffei</em>: A challenging diagnosis in a kidney transplant patient
- A Case of Epstein-Barr Virus-Negative Post-transplant Lymphoproliferative Disorder in a Solid Organ Transplant Recipient With Untreated Chronic Hepatitis C
- A disease warranting attention from neurosurgeons: primary central nervous system post-transplant lymphoproliferative disorder
- A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines
- A Pathology Experience of Posttransplant Lymphoproliferative Disorder From One Tertiary Hospital: Pathology Concepts and Diagnostic Approach
- A Rare Case of Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders With Multiple Oral Mucosal Lesions During Methotrexate Therapy
- A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL
- ABO incompatibility haploidentical peripheral blood stem cell transplantation combined with a single cord blood unit for severe aplastic anemia patients
- Allograft involvement with Post-transplant lymphoproliferative disorders (PTLD) in liver transplant recipients: A clinicopathological analysis of 17 cases
- Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders
- Autopsy Case of Epstein-Barr Virus-associated T-cell Post-transplant Lymphoproliferative Disorder with Mono- and Polymorphic Lesions: Possibility of 'Polymorphic T-cell Post-transplant Lymphoproliferative Disorder'
- Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 tria
- But Is All Post-Transplant Lymphoproliferative Disorder Created Equal?
- Case Report: Post-transplant lymphoproliferative disorder as a serious complication of vascularized composite allotransplantation
- Cat-scratch disease masquerading as post-transplant lymphoproliferative disorder
- CD56<sup>bright</sup> NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation
- Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study
- Cerebral hypometabolism in a pediatric patient with clinically resolved posterior reversible encephalopathy syndrome
- Chronological alterations in de novo malignancies after living-donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios
- Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation Patients with Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus
- Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations
- Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
- Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant
- Corrigendum to "Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type" [Transplantation Re
- Cutaneous Post-transplant Lymphoproliferative Disorder
- Cytokine Dynamics and Herpesvirus Interactions in Pediatric Liver and Kidney Transplant Recipients: The Distinct Behavior of HCMV, HHV6, HHV7 and EBV
- Cytokine Storm Syndromes Associated with Epstein-Barr Virus
- Daratumumab maintenance after autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma
- Development of progressive multifocal leukoencephalopathy after cord blood transplantation in a patient with refractory angioimmunoblastic T-cell lymphoma
- Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation
- Durable remission with lenalidomide in a patient with early relapse of adult T-cell leukemia/lymphoma after cord blood transplantation
- EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation
- Effect of pre-emptive rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium
- Effects of Pre-Transplant CONUT and Post-Transplant MRD on Prognosis of Patients with Multiple Myeloma after Auto-HSCT
- Epidemiology of Cancer in Kidney Transplant Recipients
- Epstein Barr virus-directed T-cell therapy for refractory EBV-PTLD in a toddler post Orthotopic heart transplantation
- Epstein-Barr virus associated colitis in kidney transplant patients: a case series
- Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications
- Epstein-Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada
- Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States
- Evaluation of anti-vector immune responses to adenovirus-mediated lung gene therapy and modulation by αCD20
- First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia
- First Use of Upfront Polatuzumab Vedotin in Post-transplant Lymphoproliferative Disorder: A Case Report
- Flow Cytometry as the Tool to Define Peripheral Blood Leukocyte Signatures in Acute EBV Infection
- Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report
- Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor
- Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone
- Hepatic granulomas following liver transplantation: A retrospective survey, and analysis of possible microbiological etiology
- Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial
- Immune Deficiency/Dysregulation Associated Lymphoid Proliferations, EBV+ In Persons Living With HIV
- Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma
- Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children
- Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents?
- Isolated Optic Nerve Relapse in a Pediatric Patient With T-Cell Lymphoblastic Leukemia: A Brief Report
- Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome
- Malignancy After Living Donor Liver Transplantation
- Management of immunosuppression in post-transplant lymphoproliferative disorders treated with CAR T cells
- Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience
- Membrane-bound CD95 ligand modulates CD19-mediated B cell receptor signaling and EBV activation
- Monomorphic T-cell post-transplant lymphoproliferative disorder with features of HHV8-negative primary effusion lymphoma: an autopsy case and review of the literature
- mTor-inhibition within the first days after pediatric heart transplantation is a potentially safe option to prevent cardiac allograft vasculopathy
- Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
- Neglected Right Hemidiaphragmatic Angle Soft Tissue Shadow in a Renal Transplant Recipient Diagnosed as Lymphoma
- Non-Hodgkin lymphoma in a kidney transplanted patient with methylmalonic acidemia: Metabolic susceptibility and the role of immunosuppression
- Parameters of body composition do not predict survival in patients with multiple myeloma undergoing autologous stem cell transplantation
- Pediatric Kidney Transplantation: Cancer and Cancer Risk
- Pediatric monomorphic post-transplant lymphoproliferative disorder with plasmablastic differentiation: A challenge for diagnosis and treatment
- Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma
- Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
- Post-transplant lymphoproliferative disease of two different histological types
- Post-transplant lymphoproliferative disorder after kidney transplantation with organ-specific disease
- Post-transplant lymphoproliferative disorder associated Epstein-Barr virus DNAemia after liver transplantation in children: Experience from single center
- Post-Transplant Lymphoproliferative Disorders
- Post-Transplant Lymphoproliferative Disorders (Review for Seminars in Nephrology)
- Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type
- Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial
- Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
- Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
- Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings
- Rapid rituximab administration: Safety of 60-minute infusions in malignant and benign haematological disease
- Rare Co-occurrence of Spinal Cord Hemorrhage from Radiation-induced Cavernous Hemangioma and Classical Hodgkin Lymphoma Post-transplant Lymphoproliferative Disorder
- Recurrent Acute Upper Gastrointestinal Bleed Due to Diffuse B-cell Lymphoma of the Duodenum in a Renal Transplant Patient: A Case Report and Literature Review
- Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation
- Respiratory problems associated with liver disease in children
- Successful bridging therapy with alectinib prior to allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma
- Successful Treatment of Refractory Post-Transplant Lymphoproliferative Disorder With Chimeric Antigen Receptor T-Cell Therapy in a Heart Transplant Recipient
- Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial
- Systemic Amyloidosis and Kidney Transplantation: An Update
- Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicent
- Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol
- Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database
- TCRalphabeta-depleted hematopoietic stem cell transplant and third-party CD45RA(+) depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis
- Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation
- The effect of glucose-6-phosphate dehydrogenase deficiency on allogeneic hematopoietic stem cell transplantation in patients with hematological disorders
- The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: IV-consensus guidelines for the management of post-transplant lymphoproliferative disorders in children and adolescents
- The time-dependent changes in serum immunoglobulin after kidney transplantation and its association with infection
- The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoprolifera
- Treatment of Epstein-Barr Virus infection in immunocompromised patients
- Ultrasound for monitoring different stages of post-transplant lymphoproliferative disorder in a transplanted kidney: A case report and review of the literature
- Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series